Survey results show strong member support for IACP
Results of IACP's recent member survey indicate strong support among respondents for the association and its focus on advocacy, information services and ethics.
A healthy 67 percent of respondents indicated they were highly likely to recommend membership in IACP to a colleague, with only eight percent indicating they were less likely to make such a recommendation. From those numbers, IACP's "net promoter score" - a measure of
customer loyalty to an organization - is 58.3 (see illustration at left for explanation).
"We're on the low end of very good, which isn't a bad place to be, considering the drift the association has experienced in the past five years," said IACP's executive vice president Scott Brunner. "It tells me there's plenty of goodwill and support out there that can help us grow membership, grow revenues and grow our effectiveness. For context, Apple, Southwest, American Express, companies like that tend to have NPSs in the 70s and 80s, and they tend to be among the best-loved companies out there."
The survey asked respondents to list adjectives, both positive and negative, they'd use to describe IACP. The positive adjectives far outnumbered the negative and are shown in the image at left.
"The imperative is to capitalize on that goodwill, to engage those IACP "promoters" in helping recruit new individual and corporate members," Brunner added. "That's our aim."
Respondents to the survey overwhelmingly affirmed IACP's focus on advocacy, with more than 97 percent of respondents indicating that the association's legislative, regulatory and political advocacy efforts were most important to them. The top three priorities indicated by the survey results were:
- "Protecting your compounding pharmacy via legislative and regulatory lobbying"
- "Keeping you informed about news, issues and trends impacting your compounding pharmacy."
- "Elevating the image and integrity of compounding professionals by promoting and enforcing a Compounding Code of Ethics."
In addition, respondents overwhelmingly indicated that "compliance with FDA regulation" and "navigating USP changes and compliance" were the two biggest challenges they are currently facing in their compounding business.